Katie F. Maass

The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh et al. · Ophthalmology · 2019 · 262 citations · Full text

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Nancy M. Holekamp, Peter A. Campochiaro, Margaret Chang et al. · Ophthalmology · 2021 · 169 citations · Full text

Determination of Cellular Processing Rates for a Trastuzumab-Maytansinoid Antibody-Drug Conjugate (ADC) Highlights Key Parameters for ADC Design

Katie F. Maass, Chethana Kulkarni, Alison Betts et al. · The AAPS Journal · 2016 · 75 citations · Full text

Immunocytochemical Technique, Medicine, Cellular Processing Rates +10

Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality

Katie F. Maass, Matthew Barfield, Mototsugu Ito et al. · Clinical and Translational Science · 2022 · 46 citations · Full text

Blood Samples, Patient Selection, Clinical Endpoint +23

Will patient-centric sampling become the norm for clinical trials after COVID-19?

Christopher James, Matthew Barfield, Katie F. Maass et al. · Nature Medicine · 2020 · 38 citations · Full text

Patient Selection, Covid-19 Pandemic, Patient Safety +7